Indegene Reports ₹401 Cr FY26 Profit, Plans ₹2.25 Dividend

TECH
Whalesbook Corporate News Logo
AuthorAnanya Iyer|Published at:
Indegene Reports ₹401 Cr FY26 Profit, Plans ₹2.25 Dividend
Overview

Indegene Ltd. reported a consolidated profit after tax of ₹401.1 crore on revenues of ₹3,582.5 crore for the fiscal year ended March 31, 2026. The board recommended a final dividend of ₹2.25 per share, subject to shareholder approval, and noted a ₹20.3 crore provision for a draft transfer pricing order.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • ✓Quarterly Results
  • ✓Concall Announcements
  • ✓New Orders & Big Deals
  • ✓Capex Announcements
  • ✓Bulk Deals
  • ✦And much more
Add StocksGet it on Google PlayDownload on the App Store

Indegene FY26 Performance Amidst Regulatory Updates and Dividend Plans

Indegene Limited has announced its audited financial results for the fiscal year ended March 31, 2026. The company's performance highlights a stable year, with the Board of Directors proposing a final dividend of ₹2.25 per equity share. This dividend is subject to shareholder approval at the upcoming Annual General Meeting (AGM).

Key Corporate Actions

In addition to financial reporting, the Board approved several policy amendments related to SEBI regulations, including updates for material subsidiaries and insider trading. Allotments under the company's Employee Stock Option Plan (ESOP) Scheme 2020 and Restricted Stock Unit (RSU) Scheme 2020 were also confirmed.

Transfer Pricing Matter Detailed

A significant financial disclosure involves a provision of ₹20.3 crore (₹203 million) established for a draft transfer pricing order concerning Assessment Year 2023-24. This order relates to a value of ₹111.4 crore (₹1,114 million). Indegene is engaged in a Mutual Agreement Procedure (MAP) to resolve this issue, which represents a contingent liability for the company. The fourth quarter of FY26 contributed revenue of ₹10,142 million and a profit after tax of ₹797 million to the full-year results.

About Indegene

Indegene is a global leader in digital transformation services for the life sciences sector. It provides essential technology-driven solutions to pharmaceutical, biotechnology, and healthcare organizations worldwide.

Industry Context

While Indegene operates in a specialized niche with few direct listed peers in India, companies like IQVIA Holdings Inc. offer a point of comparison within the broader life sciences data, analytics, and technology services landscape.

Looking Ahead

Shareholders will await the AGM for final approval of the proposed ₹2.25 dividend. The company is expected to soon announce the record date and the AGM date. Investors will monitor the progress of the Mutual Agreement Procedure concerning the transfer pricing dispute and any further updates on ESOP and RSU scheme allotments.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Add Stocks
Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.